Building Your Expert Care Team
At a Glance
Managing Idiopathic Pulmonary Fibrosis (IPF) requires a specialized Interstitial Lung Disease (ILD) care team, not just a general pulmonologist. Ensure your doctor participates in multidisciplinary discussions and always bring your raw HRCT imaging files to appointments.
Managing Idiopathic Pulmonary Fibrosis (IPF) is not a job for one person. Because this condition is complex and affects many aspects of your health, you need a specialized “Care Team” that works together to monitor your progress and tailor your treatment [1][2]. Establishing this team early is one of the most proactive steps you can take for your long-term health.
The Core Care Team
At the center of your care should be a specialized Interstitial Lung Disease (ILD) center [3]. Unlike a general pulmonologist who treats common issues like asthma or COPD, an ILD specialist has advanced training specifically in scarring lung diseases [4].
Your optimal team typically includes:
- ILD Pulmonologist: The “quarterback” of your care who specializes in fibrosis [2].
- Thoracic Radiologist: An imaging expert who interprets your lung scans to track the pattern of scarring [1].
- Thoracic Pathologist: A specialist who examines lung tissue if a biopsy is performed [1].
- Nurse Coordinator: Your primary point of contact for managing prescriptions, oxygen needs, and scheduling [5].
- Palliative Care Specialist: A doctor focused on “supportive care”—managing symptoms like cough and fatigue to improve your daily comfort [5][6].
Preparing for Your First Visit
When you visit an ILD specialist for the first time, the most important thing you can bring is raw data, not just summaries. Specialists need to see the actual images and numbers to form their own expert opinion [7].
Your Essential “Artifact” Checklist:
- HRCT Images on Disc: Bring the actual High-Resolution Computed Tomography (HRCT) data, usually in DICOM format on a CD or USB drive [7][8]. A paper printout or a written report is not enough for a specialist to review [7].
- Full PFT Reports: Bring the complete results (including the graphs) of any Pulmonary Function Tests you have had [9].
- Lab Results: Bring copies of recent blood work, especially tests for autoimmune markers (serology) [10].
- Pathology Slides: If you have already had a lung biopsy, ask the hospital to provide the actual glass slides or digital images for the new specialist to review [1].
Vetting Your Doctor
It is important to ensure your doctor has the specific expertise required for IPF. You can ask these three “vetting” questions during your first appointment:
- “Do you have a regular Multidisciplinary Discussion (MDD)?”: A “yes” means your case will be reviewed by a team of experts (pulmonology, radiology, and pathology) together [11][12]. This is the gold standard for accurate diagnosis [2].
- “How many IPF patients does this center manage annually?”: Experience matters. Centers of Excellence typically manage hundreds of ILD patients and are more familiar with the nuances of treatment and side effect management [3].
- “Do you participate in clinical trials?”: Even if you aren’t ready for a trial, a doctor who conducts research is often at the forefront of the newest therapies and diagnostic tools [3].
By arriving prepared and asking the right questions, you ensure that your care team is equipped to provide the highest level of expertise for your journey ahead.
Common questions in this guide
Why do I need an ILD specialist for IPF instead of a general pulmonologist?
What should I bring to my first appointment with an IPF specialist?
What is a Multidisciplinary Discussion (MDD) for IPF?
Why is a palliative care specialist part of an IPF care team?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are you an ILD (Interstitial Lung Disease) specialist, and what percentage of your practice is dedicated to patients with IPF?
- 2.Do you present your cases to a formal Multidisciplinary Discussion (MDD) team including specialized radiologists and pathologists?
- 3.Does your center participate in clinical trials for new IPF treatments?
- 4.How do you coordinate care with other specialists, such as transplant teams or palliative care providers?
- 5.Do you have a dedicated nurse coordinator who I can contact for urgent questions or medication side effects?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic pulmonary fibrosis.
Piotrowski WJ, Bestry I, Białas AJ, et al.
Advances in respiratory medicine 2020; (88(1)):41-93 doi:10.5603/ARM.2020.0081.
PMID: 32153010 - 2
Diagnostic Approaches for Idiopathic Pulmonary Fibrosis.
Lee JH, Song JW
Tuberculosis and respiratory diseases 2024; (87(1)):40-51 doi:10.4046/trd.2023.0087.
PMID: 37822232 - 3
Antifibrotic therapy in progressive pulmonary fibrosis: a review of recent advances.
Naqvi M, Hannah J, Lawrence A, et al.
Expert review of respiratory medicine 2024; (18(6)):397-407 doi:10.1080/17476348.2024.2375420.
PMID: 39039699 - 4
Interstitial Lung Disease: Update on the Role of Computed Tomography in the Diagnosis of Idiopathic Pulmonary Fibrosis.
Chen L, Halai V, Leandru A, Wallis A
Journal of computer assisted tomography 2019; (43(6)):898-905 doi:10.1097/RCT.0000000000000915.
PMID: 31453976 - 5
Idiopathic Pulmonary Fibrosis.
Lederer DJ, Martinez FJ
The New England journal of medicine 2018; (378(19)):1811-1823 doi:10.1056/NEJMra1705751.
PMID: 29742380 - 6
The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases.
Sanduzzi Zamparelli S, Sanduzzi Zamparelli A, Bocchino M
Diagnostics (Basel, Switzerland) 2023; (13(14)) doi:10.3390/diagnostics13142437.
PMID: 37510180 - 7
Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.
Khanna D, Distler O, Cottin V, et al.
Journal of scleroderma and related disorders 2022; (7(3)):168-178 doi:10.1177/23971983211064463.
PMID: 36211204 - 8
Highlights of high-resolution computed tomography imaging in evaluation of complications and co-morbidities in idiopathic pulmonary fibrosis.
Ricci F, Pugliese L, Cavallo AU, et al.
Acta radiologica (Stockholm, Sweden : 1987) 2020; (61(2)):204-218 doi:10.1177/0284185119857435.
PMID: 31237771 - 9
Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.
Hoffmann-Vold AM, Maher TM, Philpot EE, et al.
ERJ open research 2021; (7(1)) doi:10.1183/23120541.00235-2020.
PMID: 33644224 - 10
Interstitial lung disease in rheumatic diseases: an update of the 2018 review.
Atzeni F, Alciati A, Gozza F, et al.
Expert review of clinical immunology 2025; (21(2)):209-226 doi:10.1080/1744666X.2024.2407536.
PMID: 39302018 - 11
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach.
Comes A, Sgalla G, Ielo S, et al.
Expert review of respiratory medicine 2023; (17(4)):1-11 doi:10.1080/17476348.2023.2199156.
PMID: 37005289 - 12
Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 Cases.
De Sadeleer LJ, Meert C, Yserbyt J, et al.
Chest 2018; (153(6)):1416-1423 doi:10.1016/j.chest.2018.03.026.
PMID: 29608882
This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or specialized Interstitial Lung Disease center regarding your specific IPF management plan.
Get notified when new evidence is published on Idiopathic pulmonary fibrosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.